Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study-Reference-Cited by-同舟云学术

Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study

Published:2009-09 Issue:5 Volume:104 Page:651-656
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Grosse Joachim,Kramer Guus,Jakse Gerhard

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2009.08466.x/fullpdf

Reference19 articles.

1. Botulinum-A toxin in the treatment of detrusor hyperreflexia in spinal cord injury: a new alternative to medical and surgical procedures?;Stöhrer;Neurourol Urodyn,1999

2. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results;Schurch;J Urol,2000

3. Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia;Riccabona;J Urol,2004

4. Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence;Grosse;Eur Urol,2005

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AbobotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of spinal cord injury or multiple sclerosis etiology: Pooled analysis of two phase III randomized studies (CONTENT1 and CONTENT2);Neurourology and Urodynamics;2022-11-02

2. Satisfaction with Urinary Incontinence Treatments in Patients with Chronic Spinal Cord Injury;Journal of Clinical Medicine;2022-10-04

3. Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2);European Urology;2022-08

4. A review on the history, use, and new developments of abobotulinumtoxinA (Dysport);Dermatological Reviews;2022-06-23

5. BOTULINUM TOXIN, TREATMENT OPTION FOR NEUROGENIC DETRUSOR OVERACTIVITY;FARMACIA;2022-04-25